336182-49-1 Usage
Uses
Used in Pharmaceutical Synthesis:
Tert-butyl 3,3-dimethyl-4-methylidenepiperidine-1-carboxylate serves as a key building block in the pharmaceutical industry, utilized for the synthesis of a variety of medicinal compounds. Its stability and functional groups make it an ideal starting material for creating new drugs with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic chemistry, tert-butyl 3,3-dimethyl-4-methylidenepiperidine-1-carboxylate is employed as a starting material for organic synthesis reactions. Its versatility in undergoing different chemical transformations allows for the preparation of a wide range of organic compounds, contributing to the development of new chemical entities with diverse applications.
Used in the Preparation of Heterocyclic Compounds:
tert-butyl 3,3-dimethyl-4-methylidenepiperidine-1-carboxylate is also recognized for its use in the preparation of diverse heterocyclic compounds. The presence of the piperidine ring and the ability to undergo various chemical reactions make it a valuable precursor for the synthesis of complex heterocyclic structures, which are often found in biologically active molecules and have applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 336182-49-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,6,1,8 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 336182-49:
(8*3)+(7*3)+(6*6)+(5*1)+(4*8)+(3*2)+(2*4)+(1*9)=141
141 % 10 = 1
So 336182-49-1 is a valid CAS Registry Number.
336182-49-1Relevant academic research and scientific papers
Piperdine derivatives useful as CCR3 antagonists
-
Page/Page column 65, (2008/06/13)
The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment
